0001596783-21-000045.txt : 20210322
0001596783-21-000045.hdr.sgml : 20210322
20210322141956
ACCESSION NUMBER: 0001596783-21-000045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210318
FILED AS OF DATE: 20210322
DATE AS OF CHANGE: 20210322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiminski John R
CENTRAL INDEX KEY: 0001482197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 21760957
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_161643718240512.xml
FORM 4
X0306
4
2021-03-18
0
0001596783
Catalent, Inc.
CTLT
0001482197
Chiminski John R
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
1
1
0
0
Chair & CEO
Common Stock
2021-03-18
4
M
0
42220
36.02
A
205838
D
Common Stock
2021-03-18
4
S
0
42220
105.16
D
163618
D
Common Stock
2021-03-19
4
M
0
35588
36.02
A
199206
D
Common Stock
2021-03-19
4
M
0
45792
34.91
A
244998
D
Common Stock
2021-03-19
4
M
0
69270
43.88
A
314268
D
Common Stock
2021-03-19
4
M
0
32374
54.94
A
346642
D
Common Stock
2021-03-19
4
S
0
70583
105.64
D
276059
D
Common Stock
2021-03-19
4
S
0
111641
106.24
D
164418
D
Common Stock
2021-03-19
4
S
0
800
107.07
D
163618
D
Options to purchase Common Stock
36.02
2021-03-18
4
M
0
42220
0
D
2027-07-24
Common Stock
42220.0
61527
D
Options to purchase Common Stock
36.02
2021-03-19
4
M
0
35588
0
D
2027-07-24
Common Stock
35588.0
25939
D
Options to purchase Common Stock
34.91
2021-03-19
4
M
0
45792
0
D
2027-08-23
Common Stock
45792.0
15264
D
Options to purchase Common Stock
43.88
2021-03-19
4
M
0
69270
0
D
2028-07-23
Common Stock
69270.0
69273
D
Options to purchase Common Stock
54.94
2021-03-19
4
M
0
32374
0
D
2029-07-22
Common Stock
32374.0
97123
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
Includes restricted stock units.
Shares sold pursuant to the Rule 10b5-1 trading plan noted in footnote 1.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The options vest and become exercisable in four equal annual installments beginning on July 24, 2018.
The options vest and become exercisable in four equal annual installments beginning on August 23, 2018.
The options vest and become exercisable in four equal annual installments beginning on July 23, 2019.
The options vest and become exercisable in four equal annual installments beginning on July 22, 2020.
/s/ Jose Ibietatorremendia, attorney-in-fact
2021-03-22